Data Exclusivity Exceptions and Compulsory Licensing to Promote Generic Medicines in the European Union: A Proposal for Greater Coherence in European Pharmaceutical Legislation

Journal of Pharmaceutical Policy and Practice - United Kingdom
doi 10.1186/s40545-017-0107-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Policy Making on Data Exclusivity in the European Union: From Industrial Interests to Legal Realities

Journal of Health Politics, Policy and Law
Health Policy
2009English

European Union Pharmacovigilance Capabilities: Potential for the New Legislation

Therapeutic Advances in Drug Safety
Pharmacology
2015English

Driving and Diabetes: Are the Changes in the European Union Licensing Regulations Fit for Purpose?

British Journal of Diabetes
2018English

New Licensing Models for Online Music Services in the European Union: From Collective to Customized Management

SSRN Electronic Journal
2011English

The European Union and Policy Coherence for Development: Reforms, Results, Resistance

European Journal of Development Research
DevelopmentPlanningGeography
2015English

Legislation Key Milestones of Capital Market Union in the Republic of Croatia and the European Union

2019English

EU Simulations and Engagement: Motivating Greater Interest in European Union Politics

Journal of Political Science Education
EducationSociologyPolitical Science
2017English

Erratum To: Establishing Medical Plausibility in the Context of Orphan Medicines Designation in the European Union

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Managing Croatian Energy Legislation With European Union Energy Package

Megatrend revija
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy